Tropical Disease News and Research

RSS

Tropical diseases encompass all diseases that occur solely, or principally, in the tropics. In practice, the term is often taken to refer to infectious diseases that thrive in hot, humid conditions, such as malaria, leishmaniasis, schistosomiasis, onchocerciasis, lymphatic filariasis, Chagas disease, African trypanosomiasis, and dengue.

Bill & Melinda Gates Foundation grants funds for visceral leishmaniasis research

The Hebrew University of Jerusalem Kuvin Center for the Study of Infectious and Tropical Diseases has received a $5 million grant from the Bill & Melinda Gates Foundation for research into visceral leishmaniasis.

18 Dec 2009

Hebrew University of Jerusalem receives $5 million grant from Bill & Melinda Gates Foundation

17 Dec 2009

Hebrew University of Jerusalem granted $5M for research into visceral leishmaniasis in Ethiopia

17 Dec 2009

DNA reveals earliest proven case of leprosy, Turin Shroud not from Jesus-era Jerusalem

The DNA of a 1st century shrouded man found in a tomb on the edge of the Old City of Jerusalem has revealed the earliest proven case of leprosy. Details of the research will be published December 16 in the PloS ONE Journal.

16 Dec 2009

Human Rhodesian sleeping sickness in Uganda points to infected livestock movements

The northwards spread of human Rhodesian sleeping sickness in Uganda is likely due to the movement of infected livestock, according to new findings from an interdisciplinary research group including members from the Centre for Infectious Diseases, University of Edinburgh; the Ministry of Health, Uganda; and the Universities of Oxford and Southampton.

16 Dec 2009

Chagas disease transmission in Peru linked to migration and urbanization patterns

New research shows how the migration and settlement patterns associated with the rapid urbanization of Peru may link to Chagas disease transmission. The

16 Dec 2009

Sanofi Pasteur expands dengue vaccine clinical program in Latin America

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and SNY), announced today the expansion of its dengue vaccine clinical program in Latin America with a new multicenter study in children and adolescent in Mexico, Colombia, Honduras and Puerto Rico. This new multicenter study complements an earlier study in Mexico and an ongoing study in Peru.

10 Dec 2009

CDC awards Case Western Reserve University School of Medicine $19.7M for TB research

John L. Johnson, M.D., Professor of Medicine at Case Western Reserve University School of Medicine and pulmonologist at University Hospitals Case Medical Center has been awarded a 10 year, $19.7M contract from the U.S. Centers for Disease Control and Prevention (CDC) as an international clinical trials site for the Tuberculosis Trials Consortium (TBTC).

9 Dec 2009

CDC awards $19.7 million contract to study new drugs for tuberculosis treatment

8 Dec 2009

West Nile Virus can become more widespread in Europe than previously thought, says new report

Potentially fatal mosquito-borne West Nile fever (WNF) can become much more widespread in Europe than previously thought, say scientists in a new report just out in the journal BMC Evolutionary Biology(1).

8 Dec 2009

Recent releases in Global Health

Ahead of the U.N. Climate Change conference in Copenhagen next week, a Lancet comment examines the health consequences associated with climate change and the case for linking climate and health goals. "The issue now is not whether climate change is occurring, but how we can respond most effectively. ... Responding to climate change is not a distraction from the business of protecting health: it is part of the same agenda," the author writes (Chan, 12/5).

4 Dec 2009

UK DFID awards CNTD £10M in elimination of elephantiasis initiative

The Centre for Neglected Tropical Diseases (CNTD) at the Liverpool School of Tropical Medicine has been awarded £10 million by the UK Department for International Development (DFID) to support endemic countries in tackling lymphatic filariasis (LF) - a crippling disease more commonly known as elephantiasis.

3 Dec 2009

Controlling NTDs can improve reproductive health and rights of women in poor countries

Controlling neglected tropical diseases (NTDs) in developing countries would help improve the reproductive health and rights of girls and women in the poorest countries of Africa, Asia, Latin America, and the Caribbean, according to a new editorial published November 24 in the open-access journal PLoS Neglected Tropical Diseases.

2 Dec 2009

WHO issues new HIV/AIDS treatment guidelines

The WHO on Monday issued new recommendations that patients living with HIV/AIDS begin receiving antiretrovirals (ARVs) earlier than current HIV treatment advice suggests, the Associated Press reports

1 Dec 2009

NanoViricides announces filing of its quarterly report with the SEC

NanoViricides, Inc., reports that the Company has filed its quarterly report with the SEC on November 23rd.

30 Nov 2009

Community-based program proves to be successful in reducing skin infections in Australian aboriginal children

A community-based program aimed at reducing the burden of skin disease across remote communities in Australia's Northern Territory has been successful according to a study published November 24 in the open-access journal PLoS Neglected Tropical Diseases.

25 Nov 2009

OEPA reports substantial reduction of river blindness in six endemic countries

A regional initiative launched in the 1990s to eliminate onchocerciasis (river blindness) in the Americas has substantially reduced the prevalence of the disease in recent years, as evidenced by a 31% decrease in the number of individuals requiring mass drug administration in six endemic countries. Results were reported today at the 58th annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).

23 Nov 2009

Publication serves as a guide to build productive partnerships and overcome global health challenges

Meaningful and lasting progress in addressing global health challenges cannot be achieved without partnerships and collaboration, according to a publication released today, Case Studies for Global Health.

21 Nov 2009

Antimalarial drug resistance endangers malarial control measures

Evidence of resistance to the antimalarial drug artemisinin and its derivatives threatens efforts to control malaria in Southeast Asia, and experts fear artemisinin resistance may spread from the Thailand-Cambodia border to affect other malaria endemic countries. Evidence to such effect was presented today at the 58th annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).

20 Nov 2009

Pfizer,DNDi partner to Identify NTD drugs; Sanofi-Aventis, medicines for malaria launch drug study

Pfizer and the Drugs for Neglected Diseases Initiative (DNDi) on Wednesday announced plans to team up in an effort to identify new drug candidates for the treatment of three tropical diseases, the Associated Press/Business Week reports. The scientists will test the efficacy of Pfizer drug candidates against sleeping sickness, visceral leishmaniasis, and Chagas disease.

19 Nov 2009

Tropical Disease News and Research

Further Reading

Bill & Melinda Gates Foundation grants funds for visceral leishmaniasis research

Hebrew University of Jerusalem receives $5 million grant from Bill & Melinda Gates Foundation

Hebrew University of Jerusalem granted $5M for research into visceral leishmaniasis in Ethiopia

DNA reveals earliest proven case of leprosy, Turin Shroud not from Jesus-era Jerusalem

Human Rhodesian sleeping sickness in Uganda points to infected livestock movements

Chagas disease transmission in Peru linked to migration and urbanization patterns

Sanofi Pasteur expands dengue vaccine clinical program in Latin America

CDC awards Case Western Reserve University School of Medicine $19.7M for TB research

CDC awards $19.7 million contract to study new drugs for tuberculosis treatment

West Nile Virus can become more widespread in Europe than previously thought, says new report

Recent releases in Global Health

UK DFID awards CNTD £10M in elimination of elephantiasis initiative

Controlling NTDs can improve reproductive health and rights of women in poor countries

WHO issues new HIV/AIDS treatment guidelines

NanoViricides announces filing of its quarterly report with the SEC

Community-based program proves to be successful in reducing skin infections in Australian aboriginal children

OEPA reports substantial reduction of river blindness in six endemic countries

Publication serves as a guide to build productive partnerships and overcome global health challenges

Antimalarial drug resistance endangers malarial control measures

Pfizer,DNDi partner to Identify NTD drugs; Sanofi-Aventis, medicines for malaria launch drug study

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News